nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofedanol—Phenprocoumon—Phenytoin—epilepsy syndrome	0.0627	0.0658	CrCrCtD
Clofedanol—Antazoline—Phenytoin—epilepsy syndrome	0.0564	0.0591	CrCrCtD
Clofedanol—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.0473	0.0496	CrCrCtD
Clofedanol—Doxepin—Oxcarbazepine—epilepsy syndrome	0.0464	0.0486	CrCrCtD
Clofedanol—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0424	0.0444	CrCrCtD
Clofedanol—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.039	0.041	CrCrCtD
Clofedanol—Trimipramine—Carbamazepine—epilepsy syndrome	0.0385	0.0403	CrCrCtD
Clofedanol—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0368	0.0386	CrCrCtD
Clofedanol—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.0354	0.0372	CrCrCtD
Clofedanol—Imipramine—Carbamazepine—epilepsy syndrome	0.0353	0.037	CrCrCtD
Clofedanol—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.0339	0.0355	CrCrCtD
Clofedanol—Clomipramine—Clobazam—epilepsy syndrome	0.0332	0.0348	CrCrCtD
Clofedanol—Promethazine—Carbamazepine—epilepsy syndrome	0.0326	0.0342	CrCrCtD
Clofedanol—Imipramine—Oxcarbazepine—epilepsy syndrome	0.0325	0.0341	CrCrCtD
Clofedanol—Chlorprothixene—Midazolam—epilepsy syndrome	0.0325	0.0341	CrCrCtD
Clofedanol—Alimemazine—Carbamazepine—epilepsy syndrome	0.032	0.0336	CrCrCtD
Clofedanol—Benzphetamine—Phenytoin—epilepsy syndrome	0.0313	0.0329	CrCrCtD
Clofedanol—Clomipramine—Diazepam—epilepsy syndrome	0.0309	0.0324	CrCrCtD
Clofedanol—Promethazine—Oxcarbazepine—epilepsy syndrome	0.0301	0.0315	CrCrCtD
Clofedanol—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.0295	0.0309	CrCrCtD
Clofedanol—Chlorpromazine—Clobazam—epilepsy syndrome	0.0294	0.0308	CrCrCtD
Clofedanol—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.029	0.0304	CrCrCtD
Clofedanol—Chlorprothixene—Diazepam—epilepsy syndrome	0.029	0.0304	CrCrCtD
Clofedanol—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0278	0.0292	CrCrCtD
Clofedanol—Promazine—Carbamazepine—epilepsy syndrome	0.0276	0.0289	CrCrCtD
Clofedanol—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.0268	0.0281	CrCrCtD
Clofedanol—Promazine—Oxcarbazepine—epilepsy syndrome	0.0254	0.0267	CrCrCtD
Clofedanol—Disopyramide—KCND2—epilepsy syndrome	0.000575	0.0531	CrCbGaD
Clofedanol—Loperamide—CACNA1A—epilepsy syndrome	0.00032	0.0295	CrCbGaD
Clofedanol—Methadyl Acetate—OPRM1—epilepsy syndrome	0.000267	0.0246	CrCbGaD
Clofedanol—Loperamide—POMC—epilepsy syndrome	0.000222	0.0205	CrCbGaD
Clofedanol—Imipramine—KCND2—epilepsy syndrome	0.000215	0.0198	CrCbGaD
Clofedanol—Amitriptyline—KCND2—epilepsy syndrome	0.000214	0.0197	CrCbGaD
Clofedanol—Isopropamide—CHRM3—epilepsy syndrome	0.000209	0.0193	CrCbGaD
Clofedanol—Amitriptyline—KCNQ2—epilepsy syndrome	0.000199	0.0183	CrCbGaD
Clofedanol—Amitriptyline—KCNQ3—epilepsy syndrome	0.000199	0.0183	CrCbGaD
Clofedanol—Mepenzolate—CHRM3—epilepsy syndrome	0.000198	0.0182	CrCbGaD
Clofedanol—Isopropamide—CHRM1—epilepsy syndrome	0.000195	0.018	CrCbGaD
Clofedanol—Doxylamine—CHRM1—epilepsy syndrome	0.000195	0.018	CrCbGaD
Clofedanol—Mepenzolate—CHRM1—epilepsy syndrome	0.000184	0.017	CrCbGaD
Clofedanol—Diphenidol—CHRM3—epilepsy syndrome	0.000173	0.016	CrCbGaD
Clofedanol—Amitriptyline—NTRK2—epilepsy syndrome	0.000169	0.0156	CrCbGaD
Clofedanol—Orphenadrine—SCN9A—epilepsy syndrome	0.000165	0.0152	CrCbGaD
Clofedanol—Diphenidol—CHRM1—epilepsy syndrome	0.000161	0.0149	CrCbGaD
Clofedanol—Clotrimazole—CYP11A1—epilepsy syndrome	0.000159	0.0146	CrCbGaD
Clofedanol—Disopyramide—CHRM3—epilepsy syndrome	0.000158	0.0146	CrCbGaD
Clofedanol—Orphenadrine—SCN4A—epilepsy syndrome	0.000152	0.014	CrCbGaD
Clofedanol—Mepenzolate—CHRM2—epilepsy syndrome	0.00015	0.0139	CrCbGaD
Clofedanol—Disopyramide—CHRM1—epilepsy syndrome	0.000148	0.0136	CrCbGaD
Clofedanol—Dimetindene—CHRM2—epilepsy syndrome	0.000139	0.0128	CrCbGaD
Clofedanol—Diphenidol—CHRM2—epilepsy syndrome	0.000132	0.0122	CrCbGaD
Clofedanol—Dextropropoxyphene—OPRD1—epilepsy syndrome	0.000131	0.0121	CrCbGaD
Clofedanol—Loperamide—OPRD1—epilepsy syndrome	0.000125	0.0115	CrCbGaD
Clofedanol—Disopyramide—CHRM2—epilepsy syndrome	0.000121	0.0111	CrCbGaD
Clofedanol—Brompheniramine—CHRM3—epilepsy syndrome	0.000118	0.0109	CrCbGaD
Clofedanol—Levomethadyl Acetate—OPRM1—epilepsy syndrome	0.000116	0.0107	CrCbGaD
Clofedanol—Orphenadrine—SCN1A—epilepsy syndrome	0.000111	0.0102	CrCbGaD
Clofedanol—Brompheniramine—CHRM1—epilepsy syndrome	0.00011	0.0101	CrCbGaD
Clofedanol—Dextropropoxyphene—OPRM1—epilepsy syndrome	0.0001	0.00926	CrCbGaD
Clofedanol—Loperamide—OPRM1—epilepsy syndrome	9.56e-05	0.00882	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—GRM5—epilepsy syndrome	9.53e-05	0.00267	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	9.52e-05	0.00267	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—ACKR4—epilepsy syndrome	9.41e-05	0.00264	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—SSTR4—epilepsy syndrome	9.37e-05	0.00263	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—SSTR5—epilepsy syndrome	9.37e-05	0.00263	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	9.34e-05	0.00262	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CX3CR1—epilepsy syndrome	9.13e-05	0.00256	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	9.11e-05	0.00255	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CCR10—epilepsy syndrome	8.99e-05	0.00252	CbGpPWpGaD
Clofedanol—Brompheniramine—CHRM2—epilepsy syndrome	8.96e-05	0.00826	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—CX3CL1—epilepsy syndrome	8.96e-05	0.00251	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CHRM2—epilepsy syndrome	8.96e-05	0.00251	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—BDKRB1—epilepsy syndrome	8.96e-05	0.00251	CbGpPWpGaD
Clofedanol—Methadone—OPRD1—epilepsy syndrome	8.9e-05	0.00821	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	8.88e-05	0.00249	CbGpPWpGaD
Clofedanol—Clotrimazole—ABCC2—epilepsy syndrome	8.73e-05	0.00805	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—GABBR1—epilepsy syndrome	8.71e-05	0.00244	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	8.67e-05	0.00243	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	8.67e-05	0.00243	CbGpPWpGaD
Clofedanol—Chlorprothixene—CHRM3—epilepsy syndrome	8.64e-05	0.00797	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—SSTR5—epilepsy syndrome	8.51e-05	0.00239	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—SSTR4—epilepsy syndrome	8.51e-05	0.00239	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	8.49e-05	0.00238	CbGpPWpGaD
Clofedanol—Clemastine—CYP2D6—epilepsy syndrome	8.39e-05	0.00774	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—HRH3—epilepsy syndrome	8.35e-05	0.00234	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—HTR2A—epilepsy syndrome	8.26e-05	0.00231	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—OPRM1—epilepsy syndrome	8.22e-05	0.0023	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCR10—epilepsy syndrome	8.16e-05	0.00229	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	8.15e-05	0.00228	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	8.15e-05	0.00228	CbGpPWpGaD
Clofedanol—Chlorprothixene—CHRM1—epilepsy syndrome	8.05e-05	0.00743	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	8e-05	0.00224	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GRM2—epilepsy syndrome	7.86e-05	0.0022	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—AGT—epilepsy syndrome	7.83e-05	0.0022	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	7.81e-05	0.00219	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CCR3—epilepsy syndrome	7.77e-05	0.00218	CbGpPWpGaD
Clofedanol—Promethazine—CHRM3—epilepsy syndrome	7.68e-05	0.00709	CrCbGaD
Clofedanol—Doxepin—CHRM3—epilepsy syndrome	7.61e-05	0.00702	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—NPY—epilepsy syndrome	7.57e-05	0.00212	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	7.38e-05	0.00207	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CRH—epilepsy syndrome	7.3e-05	0.00205	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—OXT—epilepsy syndrome	7.3e-05	0.00205	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CCL3—epilepsy syndrome	7.3e-05	0.00205	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CXCL2—epilepsy syndrome	7.3e-05	0.00205	CbGpPWpGaD
Clofedanol—Promethazine—CHRM1—epilepsy syndrome	7.17e-05	0.00661	CrCbGaD
Clofedanol—HRH1—IL-4 Signaling Pathway—AKT1—epilepsy syndrome	7.14e-05	0.002	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GRM2—epilepsy syndrome	7.13e-05	0.002	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—SSTR3—epilepsy syndrome	7.1e-05	0.00199	CbGpPWpGaD
Clofedanol—Doxepin—CHRM1—epilepsy syndrome	7.09e-05	0.00654	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	7.01e-05	0.00196	CbGpPWpGaD
Clofedanol—Tripelennamine—CYP2D6—epilepsy syndrome	6.92e-05	0.00639	CrCbGaD
Clofedanol—Amitriptyline—OPRD1—epilepsy syndrome	6.92e-05	0.00638	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—NPY2R—epilepsy syndrome	6.81e-05	0.00191	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	6.81e-05	0.00191	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—SSTR1—epilepsy syndrome	6.81e-05	0.00191	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CCR8—epilepsy syndrome	6.81e-05	0.00191	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CCR9—epilepsy syndrome	6.81e-05	0.00191	CbGpPWpGaD
Clofedanol—Methadone—OPRM1—epilepsy syndrome	6.81e-05	0.00628	CrCbGaD
Clofedanol—Aprindine—CYP2D6—epilepsy syndrome	6.77e-05	0.00624	CrCbGaD
Clofedanol—Promazine—CHRM3—epilepsy syndrome	6.76e-05	0.00624	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—GRM4—epilepsy syndrome	6.68e-05	0.00187	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GRM3—epilepsy syndrome	6.68e-05	0.00187	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—SST—epilepsy syndrome	6.6e-05	0.00185	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CCR2—epilepsy syndrome	6.6e-05	0.00185	CbGpPWpGaD
Clofedanol—Chlorprothixene—CHRM2—epilepsy syndrome	6.58e-05	0.00607	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	6.57e-05	0.00184	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—SSTR2—epilepsy syndrome	6.56e-05	0.00184	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	6.52e-05	0.00183	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—ADRA2A—epilepsy syndrome	6.46e-05	0.00181	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—SSTR3—epilepsy syndrome	6.45e-05	0.00181	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	6.45e-05	0.00181	CbGpPWpGaD
Clofedanol—Carbinoxamine—CYP2C19—epilepsy syndrome	6.38e-05	0.00589	CrCbGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	6.38e-05	0.00179	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PRDM4—epilepsy syndrome	6.36e-05	0.00178	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PRICKLE1—epilepsy syndrome	6.36e-05	0.00178	CbGpPWpGaD
Clofedanol—Benzphetamine—ADRA2A—epilepsy syndrome	6.36e-05	0.00586	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—GRM8—epilepsy syndrome	6.33e-05	0.00177	CbGpPWpGaD
Clofedanol—Promazine—CHRM1—epilepsy syndrome	6.3e-05	0.00582	CrCbGaD
Clofedanol—Cyclobenzaprine—HTR2A—epilepsy syndrome	6.29e-05	0.0058	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—BDKRB2—epilepsy syndrome	6.21e-05	0.00174	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CXCL12—epilepsy syndrome	6.21e-05	0.00174	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—NPY2R—epilepsy syndrome	6.18e-05	0.00173	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—SSTR1—epilepsy syndrome	6.18e-05	0.00173	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCR8—epilepsy syndrome	6.18e-05	0.00173	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	6.18e-05	0.00173	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCR9—epilepsy syndrome	6.18e-05	0.00173	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CNR1—epilepsy syndrome	6.09e-05	0.00171	CbGpPWpGaD
Clofedanol—Phenoxybenzamine—ADRA2A—epilepsy syndrome	6.07e-05	0.0056	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—GRM3—epilepsy syndrome	6.07e-05	0.0017	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GRM4—epilepsy syndrome	6.07e-05	0.0017	CbGpPWpGaD
Clofedanol—Clotrimazole—CYP2C19—epilepsy syndrome	6.07e-05	0.00559	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—OPRD1—epilepsy syndrome	6.04e-05	0.00169	CbGpPWpGaD
Clofedanol—Diphenhydramine—CHRM2—epilepsy syndrome	5.97e-05	0.0055	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—SSTR2—epilepsy syndrome	5.95e-05	0.00167	CbGpPWpGaD
Clofedanol—Chlorpromazine—CHRM3—epilepsy syndrome	5.95e-05	0.00549	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—HTR7—epilepsy syndrome	5.95e-05	0.00167	CbGpPWpGaD
Clofedanol—Imipramine—CHRM3—epilepsy syndrome	5.92e-05	0.00546	CrCbGaD
Clofedanol—Amitriptyline—CHRM3—epilepsy syndrome	5.88e-05	0.00543	CrCbGaD
Clofedanol—Promethazine—CHRM2—epilepsy syndrome	5.85e-05	0.0054	CrCbGaD
Clofedanol—Doxepin—CHRM2—epilepsy syndrome	5.79e-05	0.00534	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—CCR7—epilepsy syndrome	5.79e-05	0.00162	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CHRM1—epilepsy syndrome	5.79e-05	0.00162	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—PDYN—epilepsy syndrome	5.79e-05	0.00162	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GRM1—epilepsy syndrome	5.79e-05	0.00162	CbGpPWpGaD
Clofedanol—Cyclobenzaprine—CYP2D6—epilepsy syndrome	5.75e-05	0.00531	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—GRM8—epilepsy syndrome	5.75e-05	0.00161	CbGpPWpGaD
Clofedanol—Chlorphenamine—SLC6A4—epilepsy syndrome	5.73e-05	0.00528	CrCbGaD
Clofedanol—Orphenadrine—CHRM2—epilepsy syndrome	5.64e-05	0.00521	CrCbGaD
Clofedanol—Clomipramine—ADRA2A—epilepsy syndrome	5.64e-05	0.0052	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	5.59e-05	0.00157	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ACKR4—epilepsy syndrome	5.56e-05	0.00156	CbGpPWpGaD
Clofedanol—Chlorpromazine—CHRM1—epilepsy syndrome	5.55e-05	0.00512	CrCbGaD
Clofedanol—Brompheniramine—CYP2C19—epilepsy syndrome	5.53e-05	0.0051	CrCbGaD
Clofedanol—Imipramine—CHRM1—epilepsy syndrome	5.52e-05	0.00509	CrCbGaD
Clofedanol—Amitriptyline—CHRM1—epilepsy syndrome	5.49e-05	0.00506	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—OPRD1—epilepsy syndrome	5.49e-05	0.00154	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GNAO1—epilepsy syndrome	5.49e-05	0.00154	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	5.47e-05	0.00153	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GAL—epilepsy syndrome	5.44e-05	0.00153	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CHRM3—epilepsy syndrome	5.38e-05	0.00151	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GRM5—epilepsy syndrome	5.38e-05	0.00151	CbGpPWpGaD
Clofedanol—Amitriptyline—OPRM1—epilepsy syndrome	5.29e-05	0.00488	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—CCR7—epilepsy syndrome	5.26e-05	0.00147	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PDYN—epilepsy syndrome	5.26e-05	0.00147	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GRM1—epilepsy syndrome	5.26e-05	0.00147	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CHRM1—epilepsy syndrome	5.26e-05	0.00147	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	5.19e-05	0.00145	CbGpPWpGaD
Clofedanol—Trimipramine—ADRA2A—epilepsy syndrome	5.19e-05	0.00478	CrCbGaD
Clofedanol—Tamoxifen—ABCC2—epilepsy syndrome	5.16e-05	0.00476	CrCbGaD
Clofedanol—Promazine—CHRM2—epilepsy syndrome	5.15e-05	0.00475	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—CHRM2—epilepsy syndrome	5.06e-05	0.00142	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	5.06e-05	0.00142	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SSTR4—epilepsy syndrome	5.03e-05	0.00141	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SSTR5—epilepsy syndrome	5.03e-05	0.00141	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—AVP—epilepsy syndrome	5e-05	0.0014	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GAL—epilepsy syndrome	4.94e-05	0.00139	CbGpPWpGaD
Clofedanol—Doxepin—ADRA2A—epilepsy syndrome	4.94e-05	0.00456	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—GABBR1—epilepsy syndrome	4.92e-05	0.00138	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GRM5—epilepsy syndrome	4.89e-05	0.00137	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CHRM3—epilepsy syndrome	4.89e-05	0.00137	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCR10—epilepsy syndrome	4.82e-05	0.00135	CbGpPWpGaD
Clofedanol—Atomoxetine—SLC6A4—epilepsy syndrome	4.81e-05	0.00444	CrCbGaD
Clofedanol—Toremifene—ABCB1—epilepsy syndrome	4.75e-05	0.00438	CrCbGaD
Clofedanol—Carbinoxamine—CYP2D6—epilepsy syndrome	4.73e-05	0.00437	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—HRH3—epilepsy syndrome	4.72e-05	0.00132	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CX3CR1—epilepsy syndrome	4.69e-05	0.00131	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—OPRM1—epilepsy syndrome	4.65e-05	0.0013	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—BDKRB1—epilepsy syndrome	4.6e-05	0.00129	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CHRM2—epilepsy syndrome	4.6e-05	0.00129	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CX3CL1—epilepsy syndrome	4.6e-05	0.00129	CbGpPWpGaD
Clofedanol—Tamoxifen—ABCG2—epilepsy syndrome	4.56e-05	0.00421	CrCbGaD
Clofedanol—Atomoxetine—CYP2C19—epilepsy syndrome	4.56e-05	0.00421	CrCbGaD
Clofedanol—Chlorpromazine—CHRM2—epilepsy syndrome	4.53e-05	0.00418	CrCbGaD
Clofedanol—Chlorpromazine—HTR7—epilepsy syndrome	4.51e-05	0.00416	CrCbGaD
Clofedanol—Imipramine—CHRM2—epilepsy syndrome	4.51e-05	0.00416	CrCbGaD
Clofedanol—Clotrimazole—CYP2D6—epilepsy syndrome	4.5e-05	0.00415	CrCbGaD
Clofedanol—Imipramine—HTR7—epilepsy syndrome	4.49e-05	0.00414	CrCbGaD
Clofedanol—Amitriptyline—CHRM2—epilepsy syndrome	4.48e-05	0.00413	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—GABBR1—epilepsy syndrome	4.47e-05	0.00125	CbGpPWpGaD
Clofedanol—Amitriptyline—HTR7—epilepsy syndrome	4.46e-05	0.00411	CrCbGaD
Clofedanol—Promazine—ADRA2A—epilepsy syndrome	4.39e-05	0.00405	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—CCR3—epilepsy syndrome	4.39e-05	0.00123	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	4.37e-05	0.00122	CbGpPWpGaD
Clofedanol—Clomipramine—SLC6A4—epilepsy syndrome	4.3e-05	0.00397	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HRH3—epilepsy syndrome	4.29e-05	0.0012	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—NPY—epilepsy syndrome	4.28e-05	0.0012	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	4.27e-05	0.0012	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CCR5—epilepsy syndrome	4.26e-05	0.00119	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—OPRM1—epilepsy syndrome	4.22e-05	0.00118	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GRM2—epilepsy syndrome	4.21e-05	0.00118	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR2A—epilepsy syndrome	4.16e-05	0.00117	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—OXT—epilepsy syndrome	4.13e-05	0.00116	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CRH—epilepsy syndrome	4.13e-05	0.00116	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CXCL2—epilepsy syndrome	4.13e-05	0.00116	CbGpPWpGaD
Clofedanol—Brompheniramine—CYP2D6—epilepsy syndrome	4.1e-05	0.00378	CrCbGaD
Clofedanol—Clomipramine—CYP2C19—epilepsy syndrome	4.08e-05	0.00376	CrCbGaD
Clofedanol—Phenprocoumon—ALB—epilepsy syndrome	4.05e-05	0.00373	CrCbGaD
Clofedanol—Chlorphenamine—CYP2D6—epilepsy syndrome	4.02e-05	0.00371	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—CCR3—epilepsy syndrome	3.99e-05	0.00112	CbGpPWpGaD
Clofedanol—Trimipramine—SLC6A4—epilepsy syndrome	3.96e-05	0.00365	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—AGT—epilepsy syndrome	3.95e-05	0.00111	CbGpPWpGaD
Clofedanol—Dextropropoxyphene—CYP2D6—epilepsy syndrome	3.89e-05	0.00358	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—NPY—epilepsy syndrome	3.88e-05	0.00109	CbGpPWpGaD
Clofedanol—Chlorpromazine—ADRA2A—epilepsy syndrome	3.87e-05	0.00357	CrCbGaD
Clofedanol—Amitriptyline—ADRA2A—epilepsy syndrome	3.82e-05	0.00353	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—SSTR3—epilepsy syndrome	3.81e-05	0.00107	CbGpPWpGaD
Clofedanol—Chlorpromazine—BCHE—epilepsy syndrome	3.78e-05	0.00349	CrCbGaD
Clofedanol—Doxepin—SLC6A4—epilepsy syndrome	3.77e-05	0.00348	CrCbGaD
Clofedanol—Trimipramine—CYP2C19—epilepsy syndrome	3.75e-05	0.00346	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—OXT—epilepsy syndrome	3.75e-05	0.00105	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CRH—epilepsy syndrome	3.75e-05	0.00105	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	3.75e-05	0.00105	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	3.75e-05	0.00105	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	3.73e-05	0.00105	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	3.73e-05	0.00105	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.73e-05	0.00105	CbGpPWpGaD
Clofedanol—Loperamide—CYP2D6—epilepsy syndrome	3.7e-05	0.00342	CrCbGaD
Clofedanol—Atomoxetine—HTR2A—epilepsy syndrome	3.7e-05	0.00341	CrCbGaD
Clofedanol—Diphenhydramine—CYP2C19—epilepsy syndrome	3.68e-05	0.0034	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.65e-05	0.00102	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	3.65e-05	0.00102	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	3.65e-05	0.00102	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	3.65e-05	0.00102	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	3.65e-05	0.00102	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.65e-05	0.00102	CbGpPWpGaD
Clofedanol—Tamoxifen—CYP2C19—epilepsy syndrome	3.59e-05	0.00331	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	3.58e-05	0.001	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	3.58e-05	0.001	CbGpPWpGaD
Clofedanol—Doxepin—CYP2C19—epilepsy syndrome	3.57e-05	0.0033	CrCbGaD
Clofedanol—Methadone—CYP2C19—epilepsy syndrome	3.56e-05	0.00328	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	3.52e-05	0.000986	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	3.52e-05	0.000986	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.51e-05	0.000983	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.51e-05	0.000983	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	3.44e-05	0.000965	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.43e-05	0.000962	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	3.4e-05	0.000952	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PGF—epilepsy syndrome	3.4e-05	0.000952	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	3.39e-05	0.00095	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—SST—epilepsy syndrome	3.39e-05	0.00095	CbGpPWpGaD
Clofedanol—Atomoxetine—CYP2D6—epilepsy syndrome	3.38e-05	0.00312	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	3.36e-05	0.000942	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	3.33e-05	0.000932	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.32e-05	0.000929	CbGpPWpGaD
Clofedanol—Clomipramine—HTR2A—epilepsy syndrome	3.3e-05	0.00305	CrCbGaD
Clofedanol—Chlorprothixene—HTR2A—epilepsy syndrome	3.29e-05	0.00304	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	3.25e-05	0.000912	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	3.24e-05	0.000908	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	3.24e-05	0.000908	CbGpPWpGaD
Clofedanol—Clotrimazole—ABCB1—epilepsy syndrome	3.21e-05	0.00296	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	3.2e-05	0.000897	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	3.19e-05	0.000893	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	3.19e-05	0.000893	CbGpPWpGaD
Clofedanol—Promazine—CYP2C19—epilepsy syndrome	3.18e-05	0.00293	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	3.13e-05	0.000876	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	3.12e-05	0.000873	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	3.11e-05	0.000871	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	3.11e-05	0.000871	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	3.11e-05	0.000871	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	3.11e-05	0.000871	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	3.05e-05	0.000855	CbGpPWpGaD
Clofedanol—Trimipramine—HTR2A—epilepsy syndrome	3.04e-05	0.0028	CrCbGaD
Clofedanol—Clomipramine—CYP2D6—epilepsy syndrome	3.02e-05	0.00279	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	2.96e-05	0.00083	CbGpPWpGaD
Clofedanol—Imipramine—SLC6A4—epilepsy syndrome	2.93e-05	0.00271	CrCbGaD
Clofedanol—Promethazine—HTR2A—epilepsy syndrome	2.93e-05	0.0027	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	2.92e-05	0.000819	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	2.92e-05	0.000819	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GAL—epilepsy syndrome	2.92e-05	0.000819	CbGpPWpGaD
Clofedanol—Amitriptyline—SLC6A4—epilepsy syndrome	2.92e-05	0.00269	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	2.91e-05	0.000815	CbGpPWpGaD
Clofedanol—Doxepin—HTR2A—epilepsy syndrome	2.9e-05	0.00267	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	2.89e-05	0.000809	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	2.89e-05	0.000809	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	2.89e-05	0.000809	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	2.83e-05	0.000793	CbGpPWpGaD
Clofedanol—Imipramine—CYP2C19—epilepsy syndrome	2.78e-05	0.00257	CrCbGaD
Clofedanol—Trimipramine—CYP2D6—epilepsy syndrome	2.78e-05	0.00257	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.77e-05	0.000776	CbGpPWpGaD
Clofedanol—Amitriptyline—CYP2C19—epilepsy syndrome	2.76e-05	0.00255	CrCbGaD
Clofedanol—Diphenhydramine—CYP2D6—epilepsy syndrome	2.73e-05	0.00252	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.72e-05	0.000761	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	2.72e-05	0.000761	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.72e-05	0.000761	CbGpPWpGaD
Clofedanol—Promethazine—CYP2D6—epilepsy syndrome	2.68e-05	0.00247	CrCbGaD
Clofedanol—Tamoxifen—CYP2D6—epilepsy syndrome	2.66e-05	0.00245	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	2.65e-05	0.000743	CbGpPWpGaD
Clofedanol—Doxepin—CYP2D6—epilepsy syndrome	2.65e-05	0.00244	CrCbGaD
Clofedanol—Loperamide—ABCB1—epilepsy syndrome	2.64e-05	0.00244	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	2.64e-05	0.00074	CbGpPWpGaD
Clofedanol—Methadone—CYP2D6—epilepsy syndrome	2.64e-05	0.00243	CrCbGaD
Clofedanol—Promazine—HTR2A—epilepsy syndrome	2.58e-05	0.00238	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	2.57e-05	0.00072	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	2.53e-05	0.00071	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	2.49e-05	0.000699	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.4e-05	0.000674	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	2.35e-05	0.00066	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.35e-05	0.000659	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.29e-05	0.000643	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NPY—epilepsy syndrome	2.29e-05	0.000643	CbGpPWpGaD
Clofedanol—Chlorpromazine—HTR2A—epilepsy syndrome	2.27e-05	0.00209	CrCbGaD
Clofedanol—Clomipramine—ALB—epilepsy syndrome	2.26e-05	0.00209	CrCbGaD
Clofedanol—Imipramine—HTR2A—epilepsy syndrome	2.26e-05	0.00208	CrCbGaD
Clofedanol—Amitriptyline—HTR2A—epilepsy syndrome	2.24e-05	0.00207	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	2.23e-05	0.000626	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	2.21e-05	0.00062	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CRH—epilepsy syndrome	2.21e-05	0.00062	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	2.21e-05	0.00062	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	2.21e-05	0.00062	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—OXT—epilepsy syndrome	2.21e-05	0.00062	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	2.18e-05	0.000612	CbGpPWpGaD
Clofedanol—Clomipramine—ABCB1—epilepsy syndrome	2.16e-05	0.00199	CrCbGaD
Clofedanol—Chlorprothixene—ABCB1—epilepsy syndrome	2.15e-05	0.00198	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.14e-05	0.000599	CbGpPWpGaD
Clofedanol—Chlorpromazine—CYP2D6—epilepsy syndrome	2.07e-05	0.00191	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.06e-05	0.000578	CbGpPWpGaD
Clofedanol—Imipramine—CYP2D6—epilepsy syndrome	2.06e-05	0.0019	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	2.06e-05	0.000577	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	2.06e-05	0.000577	CbGpPWpGaD
Clofedanol—Amitriptyline—CYP2D6—epilepsy syndrome	2.05e-05	0.00189	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	2.03e-05	0.000568	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SST—epilepsy syndrome	2e-05	0.000561	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	2e-05	0.000561	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	2e-05	0.000561	CbGpPWpGaD
Clofedanol—Trimipramine—ABCB1—epilepsy syndrome	1.99e-05	0.00183	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	1.98e-05	0.000556	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.96e-05	0.000549	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	1.95e-05	0.000547	CbGpPWpGaD
Clofedanol—Promethazine—ABCB1—epilepsy syndrome	1.91e-05	0.00176	CrCbGaD
Clofedanol—Tamoxifen—ABCB1—epilepsy syndrome	1.9e-05	0.00175	CrCbGaD
Clofedanol—Doxepin—ABCB1—epilepsy syndrome	1.89e-05	0.00175	CrCbGaD
Clofedanol—Methadone—ABCB1—epilepsy syndrome	1.88e-05	0.00174	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	1.88e-05	0.000527	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.88e-05	0.000527	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	1.88e-05	0.000527	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.87e-05	0.000525	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.87e-05	0.000523	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	1.85e-05	0.000518	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	1.85e-05	0.000518	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	1.84e-05	0.000516	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	1.8e-05	0.000505	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	1.75e-05	0.00049	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	1.72e-05	0.000481	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	1.71e-05	0.000478	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	1.68e-05	0.00047	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	1.67e-05	0.000468	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—S100B—epilepsy syndrome	1.59e-05	0.000445	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	1.57e-05	0.00044	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	1.57e-05	0.000439	CbGpPWpGaD
Clofedanol—Chlorpromazine—ALB—epilepsy syndrome	1.55e-05	0.00143	CrCbGaD
Clofedanol—Amitriptyline—ALB—epilepsy syndrome	1.53e-05	0.00141	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—AVP—epilepsy syndrome	1.52e-05	0.000425	CbGpPWpGaD
Clofedanol—Chlorpromazine—ABCB1—epilepsy syndrome	1.48e-05	0.00137	CrCbGaD
Clofedanol—Imipramine—ABCB1—epilepsy syndrome	1.47e-05	0.00136	CrCbGaD
Clofedanol—Amitriptyline—ABCB1—epilepsy syndrome	1.46e-05	0.00135	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—HES1—epilepsy syndrome	1.43e-05	0.000402	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—FYN—epilepsy syndrome	1.4e-05	0.000391	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.39e-05	0.00039	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.39e-05	0.000389	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.34e-05	0.000376	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.33e-05	0.000372	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.29e-05	0.000361	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.26e-05	0.000354	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.2e-05	0.000336	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.2e-05	0.000336	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.17e-05	0.000329	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—KDR—epilepsy syndrome	1.15e-05	0.000322	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	1.11e-05	0.00031	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	1.1e-05	0.000309	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—POMC—epilepsy syndrome	1.01e-05	0.000283	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	9.86e-06	0.000276	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	8.92e-06	0.00025	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—RELA—epilepsy syndrome	8.28e-06	0.000232	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	8.12e-06	0.000227	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.53e-06	0.000211	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	7.46e-06	0.000209	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—JUN—epilepsy syndrome	7.25e-06	0.000203	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	7.05e-06	0.000198	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	6.84e-06	0.000192	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—SRC—epilepsy syndrome	6.5e-06	0.000182	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	6.33e-06	0.000178	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	4.04e-06	0.000113	CbGpPWpGaD
